Viruses: tools for tumor target discovery, and agents for oncolytic therapies – an introduction.
- Published in:
- Oncogene, 2005, v. 24, n. 52, p. 7636, doi. 10.1038/sj.onc.1209035
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2005 AND VI 24 AND IP 52
Results: 17
1
2
Guest Editor.
- Published in:
- Oncogene, 2005, v. 24, n. 52, p. 7635, doi. 10.1038/sj.onc.1209036
- Publication type:
- Article
3
Oncolytic viral therapies – the clinical experience.
- Published in:
- Oncogene, 2005, v. 24, n. 52, p. 7802, doi. 10.1038/sj.onc.1209037
- By:
- Publication type:
- Article
4
Involvement of PP2A in viral and cellular transformation.
- Published in:
- Oncogene, 2005, v. 24, n. 52, p. 7746, doi. 10.1038/sj.onc.1209038
- By:
- Publication type:
- Article
5
Modulation of cell function by small transmembrane proteins modeled on the bovine papillomavirus E5 protein.
- Published in:
- Oncogene, 2005, v. 24, n. 52, p. 7756, doi. 10.1038/sj.onc.1209039
- By:
- Publication type:
- Article
6
Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus.
- Published in:
- Oncogene, 2005, v. 24, n. 52, p. 7673, doi. 10.1038/sj.onc.1209040
- By:
- Publication type:
- Article
7
Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer.
- Published in:
- Oncogene, 2005, v. 24, n. 52, p. 7720, doi. 10.1038/sj.onc.1209041
- By:
- Publication type:
- Article
8
VSV-tumor selective replication and protein translation.
- Published in:
- Oncogene, 2005, v. 24, n. 52, p. 7710, doi. 10.1038/sj.onc.1209042
- By:
- Publication type:
- Article
9
Retroviral insertional mutagenesis: past, present and future.
- Published in:
- Oncogene, 2005, v. 24, n. 52, p. 7656, doi. 10.1038/sj.onc.1209043
- By:
- Publication type:
- Article
10
Oncolytic adenoviruses – selective retargeting to tumor cells.
- Published in:
- Oncogene, 2005, v. 24, n. 52, p. 7775, doi. 10.1038/sj.onc.1209044
- By:
- Publication type:
- Article
11
Meeting product development challenges in manufacturing clinical grade oncolytic adenoviruses.
- Published in:
- Oncogene, 2005, v. 24, n. 52, p. 7792, doi. 10.1038/sj.onc.1209045
- By:
- Publication type:
- Article
12
SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation.
- Published in:
- Oncogene, 2005, v. 24, n. 52, p. 7729, doi. 10.1038/sj.onc.1209046
- By:
- Publication type:
- Article
13
Development of transcriptionally regulated oncolytic adenoviruses.
- Published in:
- Oncogene, 2005, v. 24, n. 52, p. 7763, doi. 10.1038/sj.onc.1209048
- By:
- Publication type:
- Article
14
To replicate or not to replicate: achieving selective oncolytic virus replication in cancer cells through translational control.
- Published in:
- Oncogene, 2005, v. 24, n. 52, p. 7697, doi. 10.1038/sj.onc.1209053
- By:
- Publication type:
- Article
15
Inactivating intracellular antiviral responses during adenovirus infection.
- Published in:
- Oncogene, 2005, v. 24, n. 52, p. 7686, doi. 10.1038/sj.onc.1209063
- By:
- Publication type:
- Article
16
Future prospects for oncolytic therapy.
- Published in:
- Oncogene, 2005, v. 24, n. 52, p. 7817, doi. 10.1038/sj.onc.1209064
- By:
- Publication type:
- Article
17
Viruses – seeking and destroying the tumor program.
- Published in:
- Oncogene, 2005, v. 24, n. 52, p. 7640, doi. 10.1038/sj.onc.1209047
- By:
- Publication type:
- Article